1. Home
  2. GRMLW vs SIGIP Comparison

GRMLW vs SIGIP Comparison

Compare GRMLW & SIGIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GRMLW

Greenland Mines Ltd Warrant

N/A

Current Price

$0.22

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Logo Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B

SIGIP

Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B

N/A

Current Price

$16.50

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
GRMLW
SIGIP
Founded
N/A
N/A
Country
United States
United States
Employees
5
2800
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
GRMLW
SIGIP
Price
$0.22
$16.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.0K
3.1K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$15.82
52 Week High
$0.37
$18.71

Technical Indicators

Market Signals
Indicator
GRMLW
SIGIP
Relative Strength Index (RSI) 53.95 53.00
Support Level $0.13 $16.26
Resistance Level $0.24 $16.65
Average True Range (ATR) 0.05 0.11
MACD -0.00 0.03
Stochastic Oscillator 42.98 54.57

Price Performance

Historical Comparison
GRMLW
SIGIP

About GRMLW Greenland Mines Ltd Warrant

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

About SIGIP Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B

Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. Majority of revenue is gained from Standard Commercial Lines segment, which comprises of property and casualty insurance products and services provided in the standard marketplace to commercial enterprises, which are typically businesses, non-profit organizations, and local government agencies.

Share on Social Networks: